Cabozantinib in patients with non-locally pretreated brain metastases from renal cell carcinoma: Results of the multicenter phase II trial CABRAMET
Fields of Study & Subjects
Renal cell carcinoma treatment
Brain Metastases and Treatment
Chemotherapy-induced organ toxicity mitigation
Publication details
- Journal / source
- European Journal of Cancer
- Publisher
- Elsevier BV
- Volume
- 239
- Pages
- 116712–116712
- Publication date
- 2 April 2026
- Language
- EN